Compound Detail
CHEMBL164409
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
Basic Information
| ChEMBL ID | CHEMBL164409 |
| Phase | Preclinical |
| Structure Type | MOL |
| InChI Key | BBRZZTAAAPVISM-JLVJUDLZSA-N |
2
Targets
2
Activities
1
Assay Types
0
PK Parameters
2
Publications
0
Known Names
Molecular Properties
318.4
MW (Da)
2.26
ALogP
5
HBA
1
HBD
67.9
PSA (Ų)
0.87
QED
0
Ro5 Violations
3
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| Availability | Unknown |
| Chirality | Unknown |
Activity Summary
IC50 2 meas. best 5.25
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Sodium-dependent dopamine transporter CHEMBL2986 | IC50 | 5.25 | 5.25 | 5600.0 | 1 |
| Rattus norvegicus CHEMBL376 | IC50 | 4.28 | 4.28 | 52600.0 | 1 |
Activity Data Samples
Top measurements by pChEMBL value
| Target | Type | Rel. | Value | Units | pChEMBL | Assay | PubMed |
|---|---|---|---|---|---|---|---|
| Sodium-dependent dopamine transporter | IC50 | = | 5600.0 | nM | 5.25 | In vitro inhibitory activity towards [3H]cocaine binding to rat striatal tissue | 1995895 |
| Rattus norvegicus | IC50 | = | 52600.0 | nM | 4.28 | Compound was evaluated in vitro, for the ability to inhibit [3H]- dopamine uptak... | 1995895 |
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 1995895 | 10.1021/jm00106a035 | Sodium-dependent dopamine transporter | 1 |
| 1995895 | 10.1021/jm00106a035 | Rattus norvegicus | 1 |
Data from ChEMBL 36 via Core Engine